期刊文献+

甲磺酸去铁胺治疗高血压脑出血60例分析

Analysis of 60 Cases of Hypertensive Cerebral Hemorrhage Treated with Deferoxamine Mesylate
下载PDF
导出
摘要 目的分析甲磺酸去铁胺对高血压脑出血患者的效果。方法选取本院2017年1月~2017年12月住院治疗的113例高血压脑出血患者作为研究对象,根据患者住院号奇偶数将分为对照组(53例)与研究组(60例),对照组接受常规治疗,研究组在常规治疗基础上加用甲磺酸去铁胺治疗,观察比较两组患者不同时间(第7天、第14天)相对水肿程度、相对血肿体积以及预后恢复等情况。结果研究组患者第7天、第14天相对血肿吸收量、相对血肿体积均较对照组明显改善,差异有统计学意义(P<0.05);研究组患者在第7天、第14天的NIHSS评分均低于对照组,差异有统计学意义(P<0.05)。结论甲磺酸去铁胺高血压脑出血患者治疗中的应用效果显著,不仅可以减轻患者相对血肿吸收量,而且能够有效缩小相对水肿体积,有助于促进患者神经功能恢复,改善其预后。 Objective To analyze the effect of deferoxamine mesylate on patients with hypertensive intracerebral hemorrhage. Methods A total of 113 patients with hypertensive cerebral hemorrhage admitted to our hospital from January 2017 to December 2017 were enrolled. The patients were divided into the control group (53 cases) and the study group (60 cases) according to the hospitalization number. The control group received rou- tine treatment. The study group was treated with deferoxaanine mesylate on the basis of conventional treatment. The relative edema degree, relative hematoma volume and prognosis recovery were compared between the two groups at different times (day 7 and day 14). Happening. Results The relative hematoma absorption and relative hematoma volume of the study group were significantly improved compared with the control group on the 7 th and 14 th day, the difference was statistically significant (P〈0.05). The NIHSS of the study group on the 7 th and 14 th day The scores were low- er than the control group, and the difference was statistically significant (P〈0.05). Conclusion The application of deferoxamine mesylate in the treatment of hypertensive cerebral hemorrhage is significant, which can not only reduce the relative hematoma absorption, but also effectively reduce the relative edema volume, and help to promote the recovery of neurological function and improve the prognosis of patients.
作者 熊成英 Xiong Chengying(Department ofNeurosurgery,Shangrao People's Hospital,Shangrao,Jiangxi,334000,China)
出处 《当代医学》 2018年第25期41-43,共3页 Contemporary Medicine
关键词 高血压脑出血 甲磺酸去铁胺 血肿 水肿 预后 Hypertensive cerebral hemorrhage Deferoxamine mesylate Hematoma Edema Prognosis
  • 相关文献

参考文献15

二级参考文献173

  • 1吴钢.关于高血压卒中急性期的血压调控机制与血压管理的思考[J].中国卒中杂志,2007,2(9):780-783. 被引量:13
  • 2徐永强,刘超,王阳洋,刘军,宿跃田.高血压脑出血后脑水肿的治疗进展[J].中国老年学杂志,2014,34(1):281-283. 被引量:38
  • 3刘力生.2004年中国高血压防治指南(实用本)[J].中华心血管病杂志,2004,32(12):1060-1064. 被引量:2620
  • 4各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33008
  • 5刘鸣,谢鹏.神经内科学[M].北京:人民卫生出版社,2008.
  • 6中华医学会精神科分会编.中国精神障碍分类与诊断标准[M].3版.济南:山东科学出版社,2001:31-56.
  • 7Mendelow AD, Gregson BA, Fernandes HM, et al. Early surgery versus initial conservative treatment in patients with spontaneous supratentorialintracerebralhaematomas in the International Surgical Trial in intracerebral hemorrhage ( STICH ) : a randomised trialI J~. Lancet,2005,365:387-397.
  • 8Wu G, Xi GH, Huang FP. Spontaneousintracerebral hemorrhage in humans: hematoma enlargement, clot lysis, and brain edema [ J ]. ActaNeurochir Suppl, 2006,96 : 78-80.
  • 9Qureshi AI, Tuhrim S, Broderick JP, et al. Spontaneous int-rac-erebral hemorrhage[ J]. N Engl J Med,2001,344 : 1450-1460.
  • 10Koeppen AH, Diekson AC, McEvoy JA. The cellular reactions to experimental intracerebralhemorrhage [ J ~ . J Neurol Sci, 1995, 134 : 102-112.

共引文献281

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部